The following are grant awards more than 0, 000 total costs yearly ; as reported by the Cleveland Clinic Office of Sponsored Research within the last quarter. Janet Houghton, Ph.D., Chair, Cancer Biology, was awarded .17 million over 5 years in a competitive renewal of her R01 grant "TRAIL Therapy of Rhabdomyosarcoma." Funded by the National Cancer Institute National Institutes of Health. Philip Howe, Ph.D., Cancer Biology, was awarded .54 million over 5 years in a competitive renewal of his grant "Transforming growth factor beta signaling pathways." Funded by the National Cancer Institute National Institutes of Health. This is a particular achievement, as this renewal marks years 16-20 of funding. Wendy Macklin, Ph.D., Neurosciences, was awarded .68 million over 5 years for "Signaling Pathways Controlling Myelination." Funded by the National Institutes of Health. Edward Plow, Ph.D., Chair, Molecular Cardiology, was awarded .43 million over 5 years for the T32 proposal "Training Program in Vascular Biology and Pathology." Funded by the National Institutes of Health. J. Javier Provencio, M.D., F.C.C.M., Neurosciences and the Neuroinflammation Research Center, working with his mentors Richard Ransohoff, M.D., Neurosciences and Director, Neuroinflammation Research Center, and Stanley Hazen, M.D., Ph.D., Cell Biology, and Head, Section of Preventive Cardiology and Rehabilitation, was awarded 9, 000 over 5 years for a K08 grant titled "The Role of Neutrophils in SAH [subarachnoid hemorrhage]." Funded by the National Institute of Neurological Disorders and Stroke National Institutes of Health. Robert Silverman, Ph.D., Cancer Biology, was awarded 1, 875 over 3 years for "Evaluating XMRV as an Indicator of Prostate Cancer Risk or Progression." Funded by the Department of Defense.
Be argued that because Sidney reached a gestational age of twenty-three weeks, 211 she was likely a viable fetus, and the state's interest in preserving her life prevailed over her parents' interest in refusing resuscitation. However, the following arguments can also be made: 1 ; because Sidney reached a gestational age of only twenty-three weeks and not the typical viability threshold of twenty-four weeks, the state's interest in preserving life did not outweigh the Millers' rights to make medical decisions; or 2 ; if Sidney did reach the point of viability and was thus considered a viable baby, according to Texas statutory law, the Millers, as parents, had the right to 212 consent to or refuse their baby's medical treatment. Thus, the Millers' decision to avoid resuscitation should have been honored. 4. Rights of a Severely Premature Baby Born Alive. HCA argued that a baby born alive is "entitled to the same constitutional protections as any other living being, " and that the hospital had a 213 "legal and moral obligation" to save Sidney's life. HCA further argued that it followed the "letter of the law, " and that any baby born at the hospital, whether full term or premature, is entitled to receive the best care the hospital can provide.214 However, although HCA strives to ensure that every patient, including severely premature babies, receives the best care possible, there are still procedural steps the hospital must follow before providing care--the first thing being parental consent to provide medical care.215 Here, the Millers refused to consent, and they believed it was in Sidney's best interest to be free from the aggressive and invasive medical procedures HCA chose to provide.216 IV. THE NEED FOR A MORE INCLUSIVE ACT The Texas Advance Directives Act should be amended to cover parents' medical treatment decisions regarding severely premature babies. For example, the Texas Legislature should amend the current definition of "qualified patient" to specifically and motrin. 2.8 Therapy.34 2.8.1 General aspects of therapy.34 2.8.2 Medication.35 2.8.3 Surgical therapy.41 2.8.3.1 Conservative surgery.41 2.8.3.2 Ablative surgery .42 2.8.4 Pressure treatment .43 2.8.5 Other treatment modalities .44 2.8.6 Rehabilitation .45 3 Aims of the present research.47 4 Subjects and methods .48 4.1 Enrolment of patients.48 4.2 Database and statistical methods .49 4.3 Parameters registered in the database .49 4.4 Epidemiologic concepts.50 4.5 Ethical considerations.50 5 Results and comments .51 Prevalence and incidence of Meniere's disease in Finland Study I ; .51 5.2 Regional differences in the prevalence of Meniere's disease in Finland Study II ; .53 Prognosis of hearing impairment in Meniere's disease Study III ; .55 5.4 Diagnostic policy used in Finland to confirm a suspicion of Meniere's disease Study IV ; .58 5.5 Clinical picture and treatment of Meniere's disease Study V ; .61 5.6 Audiometric configurations of Meniere's disease Study V ; .64 5.7 Regional differences in the diagnostics and treatment of Meniere's disease.65 5.8 Patient's perspective .67 6 General discussion.70 6.1 Epidemiologic and diagnostic problems.70 6.2 Problems with the therapy of Meniere's disease .71 6.3 Suggestions for the diagnosis and therapy of Meniere's disease.72 7 Summary and conclusions .77 References Appendices.
SOCIAL SECURITY ASSISTANCE WHAT SOCIAL SECURITY BENEFITS ARE AVAILABLE? Social Security Disability SSD, also known as "Title II" ; provides cash assistance to workers who are either retired or who meet Social Security's definition of "disabled." SSD is available to workers who are in the United States lawfully, worked "on the books", and paid taxes for a sufficient period of time. SSD benefits are not based on need, and you may receive them even if you have savings, property or unearned income. If you work, however, it may affect your status as "disabled." Supplemental Security Income SSI, also known as Title XVI ; provides needs-based cash assistance and is available to any disabled person, even if you have no work history, as long as you meet immigratd>